Historical shareholding details of Relique Leasfin Pvt Ltd holdings in Sterling Biotech Ltd. (STERLINBIO)

Quarterly changes of Relique Leasfin Pvt Ltd shareholding in Sterling Biotech Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Dec 2020 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Sep 2020 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Jun 2020 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Mar 2020 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Dec 2019 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Sep 2019 Relique Leasfin Private Limited 1,640,458 0.60% 1,640,458 100.00% 0 0.00%
Jun 2019 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Mar 2019 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Dec 2018 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Sep 2018 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Jun 2018 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Mar 2018 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Dec 2017 Relique Leasfin Private Limited 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Sep 2017 Relique Leasfin Pvt Ltd 1,640,458 0.66% 1,640,458 100.00% 0 0.00%
Jun 2017 Relique Leasfin Pvt Ltd 1,640,458 0.67% 1,640,458 100.00% 0 0.00%
Mar 2017 Relique Leasfin Pvt Ltd 1,640,458 0.67% 1,640,458 100.00% 0 0.00%
Dec 2016 Relique Leasfin Pvt Ltd 1,640,458 0.67% 1,640,458 100.00% 0 0.00%
Sep 2016 Relique Leasfin Private Limited 1,640,458 0.67% 1,640,458 100.00% 0 0.00%
Jun 2016 Relique Leasfin Private Limited 1,640,458 0.67% 1,640,458 100.00% 0 0.00%
Mar 2016 Relique Leasfin Private Limited 1,640,458 0.68% 1,640,458 100.00% 0 0.00%
Dec 2015 Relique Leasfin Private Limited 1,640,458 0.68% 1,640,458 100.00% 0 0.00%

View all shareholdings details of Sterling Biotech Ltd.